References: Principles of immunomodulatory drug use
Australia & New Zealand Musculoskeletal Clinical Trials Network (ANZMUSC). 9 Perioperative adjustment of DMARDs in people with inflammatory arthritis [version 4.0]. 2023; Updated 25 Oct 2023. Accessed 01 Aug 2024. https://app.magicapp.org/#/guideline/LqRV3n/section/nY9yPn
Australian Technical Advisory Group on Immunisation (ATAGI). The Australian Immunisation Handbook. 10th ed. Canberra: Australian Government Department of Health and Aged Care; 2022. Updated 9 July 2018. https://immunisationhandbook.health.gov.au/contents
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med 2021;384(5):403-16. https://www.ncbi.nlm.nih.gov/pubmed/33378609
Baillet A, Gossec L, Carmona L, Wit M, van Eijk-Hustings Y, Bertheussen H, et al. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis 2016;75(6):965-73. https://pubmed.ncbi.nlm.nih.gov/26984008/
Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, López-Jiménez J, et al. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. Jama 2019;322(2):123-33. https://pubmed.ncbi.nlm.nih.gov/31287523/
Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care & Research 2011;63(4):465-82. https://pubmed.ncbi.nlm.nih.gov/21452260/
Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, et al. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 2008;59(6):794-9. https://www.ncbi.nlm.nih.gov/pubmed/18512713
Buchbinder R, Van Doornum S, Staples M, Lassere M, March L. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study. BMC Musculoskelet Disord 2015;16(1):309. https://www.ncbi.nlm.nih.gov/pubmed/26481039
Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, et al. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev 2015;14(6):503-9. https://www.ncbi.nlm.nih.gov/pubmed/25617816
Cantini F, Niccoli L, Capone A, Petrone L, Goletti D. Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice. Expert Opin Drug Saf 2019;18(5):415-25. https://pubmed.ncbi.nlm.nih.gov/31066297/
Chou WH, McGregor B, Schmidt A, Carvalho FLF, Hirsch MS, Chang SL, et al. Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urol Oncol 2021;39(10):678-85. https://pubmed.ncbi.nlm.nih.gov/34134927/
Dagnew AF, Ilhan O, Lee WS, Woszczyk D, Kwak JY, Bowcock S, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis. Lancet Infect Dis 2019;19(9):988-1000. https://pubmed.ncbi.nlm.nih.gov/31399377/
Ding T, Ledingham J, Luqmani R, Westlake S, Hyrich K, Lunt M, et al. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. Rheumatology (Oxford) 2010;49(11):2217-9. https://www.ncbi.nlm.nih.gov/pubmed/20837498
Flint J, Panchal S, Hurrell A, van de Venne M, Gayed M, Schreiber K, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. Rheumatology (Oxford) 2016;55(9):1698-702. https://www.ncbi.nlm.nih.gov/pubmed/26750125
Fuerst M, Mohl H, Baumgartel K, Ruther W. Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Rheumatol Int 2006;26(12):1138-42. https://www.ncbi.nlm.nih.gov/pubmed/16736164
Furer V, Eviatar T, Zisman D, Peleg H, Paran D, Levartovsky D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis 2021;80(10):1330-8. https://www.ncbi.nlm.nih.gov/pubmed/34127481
Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2020;79(1):39-52. https://pubmed.ncbi.nlm.nih.gov/31413005/
Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001;60(3):214-7. https://www.ncbi.nlm.nih.gov/pubmed/11171680
Hall V, Johnson D, Torresi J. Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations. Journal of Travel Medicine 2018;25(1):tay018. https://pubmed.ncbi.nlm.nih.gov/29635641/
Hellgren K, Ballegaard C, Delcoigne B, Cordtz R, Nordström D, Aaltonen K, et al. Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study. Rheumatology (Oxford) 2021;60(8):3656-68. https://pubmed.ncbi.nlm.nih.gov/33401297/
Hellgren K, Di Giuseppe D, Smedby KE, Sundström C, Askling J, Baecklund E. Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype. Rheumatology (Oxford) 2021;60(2):809-19. https://pubmed.ncbi.nlm.nih.gov/32810256/
Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, et al. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers. Ann Rheum Dis 2017;76(1):105-11. https://www.ncbi.nlm.nih.gov/pubmed/27147709
Hirzel C, L'Huillier AG, Ferreira VH, Marinelli T, Ku T, Ierullo M, et al. Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients. Am J Transplant 2021;21(6):2246-53. https://pubmed.ncbi.nlm.nih.gov/33565711/
Hsu HC, Chang YS, Hou TY, Chen LF, Hu LF, Lin TM, et al. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study. Clin Rheumatol 2021;40(9):3755-63. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917170/
Kavanaugh A, Mease PJ, Gomez-Reino JJ, Adebajo AO, Wollenhaupt J, Gladman DD, et al. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Ann Rheum Dis 2014;73(6):1020-6. https://www.ncbi.nlm.nih.gov/pubmed/24595547
Kim SC, Pawar A, Desai RJ, Solomon DH, Gale S, Bao M, et al. Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study. Semin Arthritis Rheum 2019;49(2):222-8. https://pubmed.ncbi.nlm.nih.gov/30967248/
Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, et al. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis 2022;81(5):695-709. https://www.ncbi.nlm.nih.gov/pubmed/34972811
Mariette X, Förger F, Abraham B, Flynn AD, Moltó A, Flipo RM, et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis 2018;77(2):228-33. https://pubmed.ncbi.nlm.nih.gov/29030361/
Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011;118(2):415-22. https://www.ncbi.nlm.nih.gov/pubmed/21292109
Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 2014;132(12):1453-60. https://www.ncbi.nlm.nih.gov/pubmed/25275721
Mercer LK, Regierer AC, Mariette X, Dixon WG, Baecklund E, Hellgren K, et al. Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project. Ann Rheum Dis 2017;76(12):2025-30. https://pubmed.ncbi.nlm.nih.gov/28822981/
Nguyen CM, Mendes MA, Ma JD. Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk. PLoS Curr 2011;3:Rrn1236. https://pubmed.ncbi.nlm.nih.gov/21593964/
Pappas DA, Rebello S, Liu M, Schenfeld J, Li Y, Collier DH, et al. Therapy with Biologic Agents After Diagnosis of Solid Malignancies: Results from the Corrona Registry. J Rheumatol 2019;46(11):1438-44. https://pubmed.ncbi.nlm.nih.gov/30936285/
Pieringer H, Stuby U, Biesenbach G. The place of methotrexate perioperatively in elective orthopedic surgeries in patients with rheumatoid arthritis. Clin Rheumatol 2008;27(10):1217-20. https://www.ncbi.nlm.nih.gov/pubmed/18414965
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020;383(27):2603-15. https://www.ncbi.nlm.nih.gov/pubmed/33301246
Ramiro S, Gaujoux-Viala C, Nam JL, Smolen JS, Buch M, Gossec L, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2014;73(3):529-35. https://www.ncbi.nlm.nih.gov/pubmed/24401994
Relling MV, Schwab M, Whirl-Carrillo M, Suarez-Kurtz G, Pui CH, Stein CM, et al. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update. Clin Pharmacol Ther 2019;105(5):1095-105. https://pubmed.ncbi.nlm.nih.gov/30447069/
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017;377(12):1119-31. https://pubmed.ncbi.nlm.nih.gov/28845751/
Rosenbaum JT, Costenbader KH, Desmarais J, Ginzler EM, Fett N, Goodman SM, et al. American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity. Arthritis Rheumatol 2021;73(6):908-11. https://www.ncbi.nlm.nih.gov/pubmed/33559327
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014;58(3):e44-100. https://www.ncbi.nlm.nih.gov/pubmed/24311479
Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol 2020;72(4):529-56. https://www.ncbi.nlm.nih.gov/pubmed/32090480
Sepriano A, Kerschbaumer A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2020;79(6):760-70. https://pubmed.ncbi.nlm.nih.gov/32033941/
Singh JA, Saag KG, Bridges SL, Jr., Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2016;68(1):1-25. https://www.ncbi.nlm.nih.gov/pubmed/26545825
Soy M, Keser G, Atagunduz P, Mutlu MY, Gunduz A, Koybaşi G, et al. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review. Clin Rheumatol 2021;40(9):3533-45. https://pubmed.ncbi.nlm.nih.gov/33751280/
Stadtmauer EA, Sullivan KM, Marty FM, Dadwal SS, Papanicolaou GA, Shea TC, et al. A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood 2014;124(19):2921-9. https://pubmed.ncbi.nlm.nih.gov/25237196/
Staples MP, March L, Hill C, Lassere M, Buchbinder R. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study. BMC Rheumatol 2019;3:1. https://pubmed.ncbi.nlm.nih.gov/30886989/
van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70(3):414-22. https://www.ncbi.nlm.nih.gov/pubmed/21131643
Wadström H, Frisell T, Askling J. Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden. JAMA Intern Med 2017;177(11):1605-12. https://pubmed.ncbi.nlm.nih.gov/28975211/
Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004;141(10):764-70. https://www.ncbi.nlm.nih.gov/pubmed/15545676
Wetzman A, Lukas C, Gaujoux-Viala C, Mamtani R, Barnetche T, Combe B, et al. Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis. Arthritis Care Res (Hoboken) 2021. https://pubmed.ncbi.nlm.nih.gov/34549898/
Wong LS, Tymms KE, Buckley NA. Potential for methotrexate exposure through contamination during parenteral use as an immunosuppressant. Intern Med J 2009;39(6):379-83. https://www.ncbi.nlm.nih.gov/pubmed/19580617
Wong PKK, Bagga H, Barrett C, Hanrahan P, Johnson D, Katrib A, et al. A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia. Internal Medicine Journal 2017;(5):491-500. https://www.ncbi.nlm.nih.gov/pubmed/28101910
Xie W, Xiao S, Huang Y, Sun X, Gao D, Ji L, et al. A meta-analysis of biologic therapies on risk of new or recurrent cancer in patients with rheumatoid arthritis and a prior malignancy. Rheumatology (Oxford) 2020;59(5):930-9. https://pubmed.ncbi.nlm.nih.gov/31620795/
Yoo DH, Hrycaj P, Miranda P, Ramiterre E, Piotrowski M, Shevchuk S, et al. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. Ann Rheum Dis 2013;72(10):1613-20. https://www.ncbi.nlm.nih.gov/pubmed/23687260
